Now PAT employs 40 people, half of whom are part of the Research department.
Now PAT employs 40 people, half of whom are part of the Research department.
PLANT ADVANCED TECHNOLOGIES PAT was founded in 2005 in Nancy taking advantage of a new technology, PAT plant milking®, originated from the University of Lorraine (INPL-INRA, Institut National Polytechnique de Lorraine). The three co-founders of the company are Jean-Paul Fèvre, President and CEO, Pr. Frédéric Bourgaud, Vice-President Research and Pr. Eric Gontier.
Newly created, PAT developped new proprietary technologies such as PAT Friday, an innovative platform for the production of recombinant proteins in the liquid of carnivorous plants.
PAT is registered in the Paris NYSE Euronext’s equities market (ISIN FR0010785790). The firm raises 2 millions euros in 2 years. Currently Plant Advanced Technologies PAT has over 2,400 shareholders.
PAT take over a company specialized in custom-made synthetic chemistry (Synthelor). This encourages a diversification of the competences in the enterprise as this chemistry is a complementary activity to produce and optimize active plant extracts.
The first industrial production contract is completed for a worldwide cosmetic group for the supply of an innovative and polyactive anti-ageing Exudactive®.
4 hectares of greenhouses are acquired in Lorraine (France) to meet the customers’ growing demands in innovative natural extracts. Thus, the research and production area grows, as well as R&D and production investments.
The company is certified ISO90001-2008 (by LRQA) for its entire activity, a proof of quality that insure traceability and better organisation control.
3 new active ingredients are launched in cosmetic including one with the Expanscience Laboratories.
PAT headquarters move up to their new own facilites still in Vandoeuvre-lès-Nancy-France.
Creation of Temisis subsidiary in December 2017 in Nancy (France), based on the discovery of original compounds with remarkable anti-inflammatory properties.
Launch of EquibiomeTM , new active ingredient co-developed with Seppic.
An innovative anti-inflammatory is brought to the subsidiary Temisis through a 2,5M€ valorization.
Certification ISO 9001-2015.
The subsidiary Couleurs de Plantes signs a partnership with Guangdong Yinxiangpai Garments specialized in designing and producing premium quality cashmere clothing.
The subsidiary Temisis discovers an innovative “first-in-class” mechanism of action to its anti-inflammatory in development.
PAT signs with Clariant a strategic partnership for the co-development of collection products and the exclusive distribution in the cosmetic field.
Creation of Cellengo, PAT’s subsidiary specialized in microbial fermentation
Launch of the first co-developed products with Clariant as part of its collaboration with PAT :
Creation of Cellengo, PAT’s subsidiary specialized in microbial fermentation and regrouping its Metabolic Engineering activities.
The company owns a diversified portfolio of tens of international patents and 9 trademarks.
Today, PAT employs 40 people, half of whom are part of the Research department.
March 6th, 2020,
After important breakthroughs in the development of plant active ingredients achieved through microbial synthesis, Plant Advanced Technologies PAT decided to create Cellengo on March 6th, 2020, a 100% owned subsidiary.
December 2017
Temisis, a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing a strong inflammatory component.
